Nvidia Corp vs Stryker Corporation — how do they compare? Nvidia Corp trades at $220.29 (market cap $5.27T), while Stryker Corporation trades at $347.4 (market cap $133.54B). The key difference: Nvidia Corp is far larger — about 39.5× Stryker Corporation's market cap, and Stryker Corporation pays the higher dividend (1.01%). Which is the better fit depends on your goals.
| NVDA | SYK | |
|---|---|---|
Market Cap | $5.27T | $133.54B |
Sector | Technology | Technology |
52-Week High | $235.75 | $394.34 |
52-Week Low | $165.17 | $282.58 |
Enterprise Value | $5.20T | $145.01B |
Dividend Yield | 0.46% | 1.01% |
Signals from Pluang's Aura AI — not financial advice
NVIDIA (NVDA) trades at $217.56, down 2.86% over the past 24 hours, with a bullish technical signal from moving averages and a neutral stance from oscillators. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $1.87 exceeding the $1.76 estimate. Revenue surged to $130.50B in 2025, driving a net income margin of 62.97% and robust cash flow from operations of $64.09B. Analyst sentiment remains overwhelmingly positive, with a consensus price target of $325.86.
The outlook for NVDA is favorable, supported by accelerating AI chip demand and a dominant market position. Key opportunities include sustained revenue growth and expanding profitability, while risks involve heightened competition, potential peak AI spending, and market volatility. The stock's current valuation metrics, such as a P/E of 33.31, reflect high growth expectations that must be met to justify further upside.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
NVIDIA Corporation designs, develops, and markets three dimensional (3D) graphics processors and related software. The Company offers products that provides interactive 3D graphics to the mainstream personal computer market.
Read more on NVDA →Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →